Long Term Debt Summary of Biocure Technology Inc.

Biocure Technology Inc.'s latest annual long term debt in 2023 was 41.87 Thousand CAD , down 0.0% from previous year.
Biocure Technology Inc.'s latest quarterly long term debt in 2024 Q1 was 43.67 Thousand USD , up 4.3% from previous quarter.
Biocure Technology Inc. reported annual long term debt of - USD in 2022, down -100.0% from previous year.
Biocure Technology Inc. reported annual long term debt of 991.22 Thousand CAD in 2021, down -56.75% from previous year.
Biocure Technology Inc. reported quarterly long term debt of 33.28 Thousand USD for 2024 Q2, up 4.3% from previous quarter.
Biocure Technology Inc. reported quarterly long term debt of - USD for 2023 Q2, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Biocure Technology Inc. (2023 - 2007)

Historical Annual Long Term Debt of Biocure Technology Inc. (2023 - 2007)

Year	Long Term Debt	Long Term Debt Growth
2023	41.87 Thousand CAD	0.0%
2022	- USD	-100.0%
2021	991.22 Thousand CAD	-56.75%
2020	2.29 Million CAD	6.9%
2019	2.14 Million CAD	162.98%
2018	815.18 Thousand CAD	0.0%
2017	- CAD	-100.0%
2016	647.82 Thousand CAD	-8.13%
2015	705.16 Thousand CAD	0.0%
2014	- CAD	0.0%
2013	- CAD	0.0%
2012	- CAD	0.0%
2011	- CAD	0.0%
2010	- CAD	0.0%
2009	- CAD	0.0%
2008	- CAD	0.0%
2007	- CAD	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q1	43.67 Thousand USD	4.3%
2024 Q2	33.28 Thousand USD	4.3%
2023 Q2	- USD	0.0%
2023 Q1	- USD	0.0%
2023 Q4	41.87 Thousand USD	0.0%
2023 Q3	- USD	0.0%
2023 FY	41.87 Thousand CAD	0.0%
2022 Q4	- USD	-100.0%
2022 FY	- USD	-100.0%
2022 Q1	969.25 Thousand CAD	-2.22%
2022 Q2	925.72 Thousand CAD	-4.49%
2022 Q3	840.16 Thousand CAD	-9.24%
2021 Q4	991.22 Thousand CAD	-52.38%
2021 Q2	2.23 Million CAD	0.51%
2021 FY	991.22 Thousand CAD	-56.75%
2021 Q1	2.21 Million CAD	-24.07%
2021 Q3	2.08 Million CAD	-6.7%
2020 Q1	2.88 Million CAD	3.61%
2020 FY	2.29 Million CAD	6.9%
2020 Q2	2.82 Million CAD	-1.96%
2020 Q4	2.92 Million CAD	2.28%
2020 Q3	2.85 Million CAD	1.23%
2019 Q1	789 Thousand CAD	-3.21%
2019 Q2	1.14 Million CAD	44.85%
2019 Q4	2.77 Million CAD	76.57%
2019 Q3	1.57 Million CAD	37.76%
2019 FY	2.14 Million CAD	162.98%
2018 Q2	- CAD	0.0%
2018 Q4	815.18 Thousand CAD	0.0%
2018 FY	815.18 Thousand CAD	0.0%
2018 Q1	- CAD	0.0%
2018 Q3	- CAD	0.0%
2017 Q3	962.97 Thousand CAD	-2.96%
2017 FY	- CAD	-100.0%
2017 Q1	- CAD	-100.0%
2017 Q2	992.33 Thousand CAD	0.0%
2017 Q4	- CAD	-100.0%
2016 FY	647.82 Thousand CAD	-8.13%
2016 Q4	647.82 Thousand CAD	0.0%
2016 Q3	- CAD	0.0%
2016 Q2	- CAD	0.0%
2016 Q1	- CAD	0.0%
2015 FY	705.16 Thousand CAD	0.0%
2015 Q3	- CAD	0.0%
2015 Q4	- CAD	0.0%
2015 Q1	- CAD	0.0%
2015 Q2	- CAD	0.0%
2014 Q2	- CAD	0.0%
2014 Q1	- CAD	0.0%
2014 Q3	- CAD	0.0%
2014 Q4	- CAD	0.0%
2014 FY	- CAD	0.0%
2013 Q3	- CAD	0.0%
2013 Q4	- CAD	0.0%
2013 FY	- CAD	0.0%
2013 Q1	- CAD	0.0%
2013 Q2	- CAD	0.0%
2012 FY	- CAD	0.0%
2012 Q2	- CAD	0.0%
2012 Q4	- CAD	0.0%
2012 Q3	- CAD	0.0%
2012 Q1	- CAD	0.0%
2011 Q3	- CAD	0.0%
2011 Q1	- CAD	0.0%
2011 Q2	- CAD	0.0%
2011 FY	- CAD	0.0%
2011 Q4	- CAD	0.0%
2010 Q2	- CAD	0.0%
2010 FY	- CAD	0.0%
2010 Q4	- CAD	0.0%
2010 Q1	- CAD	0.0%
2010 Q3	- CAD	0.0%
2009 Q4	- CAD	0.0%
2009 FY	- CAD	0.0%
2009 Q2	- CAD	0.0%
2009 Q1	- CAD	0.0%
2009 Q3	- CAD	0.0%
2008 Q2	- CAD	0.0%
2008 Q1	- CAD	0.0%
2008 Q3	- CAD	0.0%
2008 Q4	- CAD	0.0%
2008 FY	- CAD	0.0%
2007 Q4	- CAD	0.0%
2007 FY	- CAD	0.0%

Peer Long Term Debt Comparison of Biocure Technology Inc.

Name	Long Term Debt	Long Term Debt Difference
Qrons Inc.	80 Thousand USD	47.656%
Santhera Pharmaceuticals Holding AG	1.75 Million USD	97.615%
Nascent Biotech, Inc.	- USD	-Infinity%
Adynxx, Inc.	- USD	-Infinity%
Acro Biomedical Co., Ltd.	- USD	-Infinity%
Capstone Therapeutics Corp.	8.26 Million USD	99.493%
BioStem Technologies, Inc.	265.63 Thousand USD	84.236%
CSL Limited	11.23 Billion USD	100.0%
Arch Therapeutics, Inc.	- USD	-Infinity%
Evofem Biosciences, Inc.	8000.00 USD	-423.438%
Northwest Biotherapeutics, Inc.	20.31 Million USD	99.794%
Regen BioPharma, Inc.	149.61 Thousand USD	72.011%
Skye Bioscience, Inc.	171.23 Thousand USD	75.545%
ProtoKinetix, Incorporated	- USD	-Infinity%
Rebus Holdings, Inc.	- USD	-Infinity%
Burzynski Research Institute, Inc.	- USD	-Infinity%
Neon Bloom, Inc.	- USD	-Infinity%
Eiger BioPharmaceuticals, Inc.	- USD	-Infinity%
Nanobac Pharmaceuticals, Incorporated	- USD	-Infinity%
Institute of Biomedical Research Corp.	- USD	-Infinity%
SQZ Biotechnologies Company	20.9 Million USD	99.8%
Intellipharmaceutics International Inc.	- USD	-Infinity%
Propanc Biopharma, Inc.	58.64 Thousand USD	28.592%
Mesoblast Limited	100.29 Million USD	99.958%
Marizyme, Inc.	667.12 Thousand USD	93.723%
Genus plc	228.2 Million USD	99.982%
VioQuest Pharmaceuticals, Inc.	- USD	-Infinity%
Pharming Group N.V.	166.1 Million USD	99.975%
Therapeutic Solutions International, Inc.	5512.00 USD	-659.706%
CNBX Pharmaceuticals Inc.	- USD	-Infinity%
Nymox Pharmaceutical Corporation	- USD	-Infinity%
ContraFect Corporation	2.21 Million USD	98.105%
PsyBio Therapeutics Corp.	- USD	-Infinity%
Sienna Biopharmaceuticals, Inc.	- USD	-Infinity%
RegeneRx Biopharmaceuticals, Inc.	1.4 Million USD	97.015%
IMV Inc.	27.39 Million USD	99.847%
AXIM Biotechnologies, Inc.	5.42 Million USD	99.228%
MultiCell Technologies, Inc.	36.43 USD	-114846.473%
ONE Bio Corp.	592.19 Thousand USD	92.929%
Accustem Sciences Inc.	- USD	-Infinity%
RVL Pharmaceuticals plc	55.61 Million USD	99.925%
Arno Therapeutics, Inc.	- USD	-Infinity%
EV Biologics, Inc.	- USD	-Infinity%
Q BioMed Inc.	- USD	-Infinity%
Emmaus Life Sciences, Inc.	2.22 Million USD	98.119%
Mosaic ImmunoEngineering Inc.	1.22 Million USD	96.591%
Biomind Labs Inc.	- USD	-Infinity%
American Oriental Bioengineering, Inc.	554.59 Thousand USD	92.449%
Provectus Biopharmaceuticals, Inc.	25.29 Thousand USD	-65.52%
TetraLogic Pharmaceuticals Corporation	- USD	-Infinity%
Oncotelic Therapeutics, Inc.	1.89 Million USD	97.794%
GlobeStar Therapeutics Corporation	- USD	-Infinity%
THC Farmaceuticals, Inc.	- USD	-Infinity%
Curative Biotechnology, Inc.	- USD	-Infinity%
GB Sciences, Inc.	322 Thousand USD	86.995%
Alpha Cognition Inc.	- USD	-Infinity%
HST Global, Inc.	- USD	-Infinity%
Wesana Health Holdings Inc.	- USD	-Infinity%
Halberd Corporation	150 Thousand USD	72.083%
Enzolytics Inc.	- USD	-Infinity%
Agentix Corp.	- USD	-Infinity%
Resverlogix Corp.	- USD	-Infinity%
Nuo Therapeutics, Inc.	164.2 Thousand USD	74.498%
MetaStat, Inc.	- USD	-Infinity%
argenx SE	15.35 Million USD	99.727%
Enzon Pharmaceuticals, Inc.	- USD	-Infinity%
Endonovo Therapeutics, Inc.	- USD	-Infinity%
RespireRx Pharmaceuticals Inc.	- USD	-Infinity%
GeneThera, Inc.	- USD	-Infinity%
Inhibitor Therapeutics, Inc.	- USD	-Infinity%
AVAX Technologies, Inc.	- USD	-Infinity%
Zenith Capital Corp.	4456.00 USD	-839.744%
Genscript Biotech Corporation	287.12 Million USD	99.985%
Ember Therapeutics, Inc.	- USD	-Infinity%
Anthera Pharmaceuticals, Inc.	- USD	-Infinity%
Sigyn Therapeutics, Inc.	126.3 Thousand USD	66.845%
WPD Pharmaceuticals Inc.	229.29 Thousand USD	81.737%
Cotinga Pharmaceuticals Inc.	- USD	-Infinity%
Kadimastem Ltd	229.69 Thousand USD	81.769%
Helix BioMedix, Inc.	- USD	-Infinity%
VitaSpring Biomedical Co. Ltd.	- USD	-Infinity%
Oncology Pharma Inc.	- USD	-Infinity%
Reve Technologies, Inc.	1064.00 USD	-3835.62%
LadRx Corporation	- USD	-Infinity%
Cell Source, Inc.	- USD	-Infinity%
Regen BioPharma, Inc.	149.61 Thousand USD	72.011%
NovAccess Global Inc.	- USD	-Infinity%
Affymax, Inc.	- USD	-Infinity%
Itoco Inc.	- USD	-Infinity%
Rasna Therapeutics, Inc.	- USD	-Infinity%
Pathfinder Cell Therapy, Inc.	- USD	-Infinity%
Mobile Lads Corp.	- USD	-Infinity%
CytoDyn Inc.	141 Thousand USD	70.301%
Claritas Pharmaceuticals, Inc.	- USD	-Infinity%
NDT Pharmaceuticals Inc.	- USD	-Infinity%
NanoSphere Health Sciences Inc.	- USD	-Infinity%
Alseres Pharmaceuticals, Inc.	7.81 Million USD	99.465%
SYBLEU INC	300 Thousand USD	86.042%
Advanced Proteome Therapeutics Corporation	- USD	-Infinity%
ImmunoCellular Therapeutics, Ltd.	369.04 Thousand USD	88.653%
International Stem Cell Corporation	445 Thousand USD	90.59%
Bioxytran, Inc.	- USD	-Infinity%
GlobeImmune, Inc.	- USD	-Infinity%
Predictive Technology Group, Inc.	- USD	-Infinity%
ProText Mobility, Inc.	- USD	-Infinity%
Cardax, Inc.	- USD	-Infinity%
VG Life Sciences Inc.	- USD	-Infinity%
Kaleido Biosciences, Inc.	- USD	-Infinity%
Advaxis, Inc.	8.15 Million USD	99.486%
Adhera Therapeutics, Inc.	- USD	-Infinity%
RenovaCare, Inc.	- USD	-Infinity%
Regnum Corp.	- USD	-Infinity%
Innovation Pharmaceuticals Inc.	457 Thousand USD	90.837%
Neutra Corp.	- USD	-Infinity%
Windtree Therapeutics, Inc.	1.16 Million USD	96.393%
PureTech Health plc	18.25 Million USD	99.771%
Coeptis Therapeutics, Inc.	150 Thousand USD	72.083%
IXICO plc	275 Thousand USD	84.773%
IntelGenx Technologies Corp.	11.83 Million USD	99.646%
Gelesis Holdings, Inc.	26.3 Million USD	99.841%
CSL Limited	11.23 Billion USD	100.0%
Cellectis S.A.	36.21 Million USD	99.884%

Global Stocks Search

Biocure Technology Inc. (BICTF)

Long Term Debt Summary of Biocure Technology Inc.

Annual Long Term Debt Chart of Biocure Technology Inc. (2023 - 2007)

Historical Annual Long Term Debt of Biocure Technology Inc. (2023 - 2007)

Peer Long Term Debt Comparison of Biocure Technology Inc.